info icon

This is a non-core endpoint: only basic statistics are computed.

Carcinoma in situ of other/unspecified female genital organs

CD2_INSITU_FEM_GENITAL_NOS_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only females

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D07.3&
  • Hospital discharge: ICD-9 2333X
  • Cause of death: ICD-10 D07.3&
  • Cause of death: ICD-9 2333X

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ organorum genitalium femininorum aliorum sive non specificatorum

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 18 18 -
Unadjusted period prevalence (%) 0.01 0.01 -
Median age at first event (years) 47.85 47.85 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
10
35
5.12
2.81
1.6
1.8
—
—
—
0
0
5
11
5.82
2.09
3.2
1.5
46.8
108.1
u/ml
—
5
11
5
13
4.88
1.85
2.0
2.7
—
—
—
0
0
9
51
2.52
1.19
2.6
3.2
—
—
—
0
0
5
28
2.08
0.72
1.4
1.6
—
—
—
0
0
9
60
1.99
0.71
4.4
1.7
—
—
—
0
0
6
38
1.86
0.62
2.0
2.5
—
7.4
—
0
6
10
77
1.67
0.48
7.5
3.6
9.4
10.1
umol/l
—
10
68
5
31
1.84
0.48
1.6
2.1
—
—
—
0
0
0
16
0.00
0.43
0.0
1.4
—
—
—
0
0
0
16
0.00
0.43
0.0
2.6
—
—
—
0
0
6
41
1.69
0.42
3.0
2.5
8.6
7.5
mmol/l
—
6
32
12
100
1.60
0.34
3.4
3.3
—
—
—
0
0
10
82
1.49
0.33
3.1
3.7
6.3
6.6
mmol/l
—
10
76
6
49
1.33
0.23
1.5
2.0
52.0
54.2
u/l
—
6
44
0
11
0.00
0.22
0.0
1.2
—
66.6
—
0
11
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
0
12
0.00
0.22
0.0
2.3
—
3.3
—
0
12
0
12
0.00
0.22
0.0
1.3
—
—
—
0
0
9
76
1.37
0.21
10.4
6.7
3.9
4.4
e9/l
—
9
67
10
111
0.78
0.21
3.3
4.0
—
—
—
0
0
8
69
1.29
0.21
4.0
5.7
0.6
0.5
e9/l
—
8
64
5
42
1.26
0.11
2.6
1.3
—
—
—
0
0
5
59
0.79
0.10
6.2
6.6
0.0
0.0
e9/l
—
5
50
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
7
66
1.10
0.00
2.3
2.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
91.7
—
0
5
0
7
0.00
0.00
0.0
3.4
—
24.4
—
0
7
0
5
0.00
0.00
0.0
1.4
—
8.5
—
0
5
0
7
0.00
0.00
0.0
1.3
—
0.2
—
0
7
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
1.1
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
5.0
—
0
5
5
51
0.97
0.00
6.8
3.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
7.7
—
74.6
—
0
7
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_FEM_GENITAL_NOS_EXALLC – Carcinoma in situ of other/unspecified female genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).